REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Amryt Pharma chairman makes share purchase

Mon, 15th Mar 2021 16:38

(Sharecast News) - Amryt Pharma revealed on Monday that chairman Ram Stafford had acquired 300,100 ordinary shares in the AIM-listed commercial-stage biopharmaceutical company.
Stafford, who previously headed up Sudocrem owner Tosara Group, purchased the shares on Friday at an average price of 200.0p per share, for a total value of £600,200.

Last week, Amryt announced the signing of a distribution agreement with Medison Pharma to distribute its Myalepta product in Canada.

Amryt said the agreement completed its multi-regional distribution deals with Medison, first announced in February, to distribute Myalepta and Lojuxta in Israel and Juxtapid in Canada.

As of 1645 GMT, Amryt shares were up 3.54% at 205.0p.

Top Director Buys

Amryt Pharma (AMYT)
Director name: Stafford,Ray
Amount purchased: 300,100 @ 200.00p
Value: £600,200.00

Newriver Reit (NRR)
Director name: Lockhart,Allan
Amount purchased: 224,489 @ 97.58p
Value: £219,056.36

Newriver Reit (NRR)
Director name: Davies,Mark
Amount purchased: 185,000 @ 96.20p
Value: £177,970.00

Photo-me International (PHTM)
Director name: Crasnianski,Serge
Amount purchased: 282,029 @ 51.11p
Value: £144,145.02

Photo-me International (PHTM)
Director name: Crasnianski,Serge
Amount purchased: 250,000 @ 51.35p
Value: £128,374.99

Edinburgh Worldwide Inv Trust (EWI)
Director name: Wilson,Mungo
Amount purchased: 35,613 @ 350.50p
Value: £124,823.57

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 95,000,000 @ 0.09p
Value: £86,402.50

Serco Group (SRP)
Director name: Lodge,Tim
Amount purchased: 40,000 @ 127.20p
Value: £50,880.00

Frenkel Topping Group (FEN)
Director name: Mills,Christopher
Amount purchased: 100,000 @ 45.00p
Value: £45,000.00

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 37,000,000 @ 0.09p
Value: £31,524.00

F&c Investment Trust (FCIT)
Director name: Joy,Tom
Amount purchased: 3,500 @ 788.86p
Value: £27,610.10

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 18,000,000 @ 0.09p
Value: £16,830.00

Lxi Reit (LXI)
Director name: Dimond,Patricia
Amount purchased: 8,005 @ 124.92p
Value: £9,999.53

Rockfire Resources (ROCK)
Director name: Walley,Nicholas
Amount purchased: 536,000 @ 0.95p
Value: £5,092.00

F&c Investment Trust (FCIT)
Director name: Ecsery,Francesca
Amount purchased: 380 @ 783.48p
Value: £2,977.24



Top Director Sells

Pagegroup (PAGE)
Director name: Ingham,Stephen
Amount sold: 41,638 @ 480.10p
Value: £199,904.04

Newriver Reit (NRR)
Director name: Davies,Mark
Amount sold: 185,000 @ 96.20p
Value: £177,970.00

Dukemount Capital (DKE)
Director name: Dart,Geoffrey
Amount sold: 27,000,000 @ 0.60p
Value: £162,000.00

Newriver Reit (NRR)
Director name: Lockhart,Allan
Amount sold: 133,745 @ 97.20p
Value: £130,000.14

Pagegroup (PAGE)
Director name: Stagg ,Kelvin
Amount sold: 20,774 @ 480.10p
Value: £99,735.98

Cropper (james) (CRPR)
Director name: Maddock,Isabelle
Amount sold: 500 @ 1,100.00p
Value: £5,500.00

More News
30 Mar 2021 12:11

Amryt releases data from Italy lomitapide study

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma released efficacy and safety data from the 'Lochnes' investigator-sponsored study of lomitapide in familial chylomicronemia syndrome (FCS) on Tuesday, which was conducted by expert lipidologists in Italy.

Read more
29 Mar 2021 09:15

European approval for Amryt's Oleogel-S10 moves closer

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced the validation of its marketing authorisation application for 'Oleogel-S10' by the European Medicines Agency on Monday, for the potential treatment of cutaneous manifestations of junctional and dystrophic epidermolysis bullosa.

Read more
23 Mar 2021 19:03

IN BRIEF: Amryt gets positive feedback on Myalept from US regulator

IN BRIEF: Amryt gets positive feedback on Myalept from US regulator

Read more
23 Mar 2021 09:34

Amryt upbeat on positive FDA feedback

(Sharecast News) - Commercial-stage biopharmaceuticals company Amryt Pharma has received further feedback from the United States Food and Drug Administration (FDA) on Myalept, it said on Tuesday, and its proposed development plan and study design to support an indication for patients with partial lipodystrophy (PL).

Read more
22 Mar 2021 19:07

IN BRIEF: Amryt's Myalepta secures reimbursement approval in France

IN BRIEF: Amryt's Myalepta secures reimbursement approval in France

Read more
22 Mar 2021 09:04

Amryt's Myalepta gets reimbursement approval in France

(Sharecast News) - Commercial-stage biopharmaceuticals company Amryt Pharma announced on Monday that the French Ministry of Social Affairs and Health has approved 'Myalepta', or metreleptin, for reimbursement in the country as an adjunct to diet as replacement therapy.

Read more
9 Mar 2021 06:55

IN BRIEF: Amryt, Medison sign distribution deal for Myalepta in Canada

IN BRIEF: Amryt, Medison sign distribution deal for Myalepta in Canada

Read more
8 Mar 2021 12:19

Amryt Pharma signs another distribution deal with Medison

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced the signing of a distribution agreement with Medison Pharma to distribute 'Myalepta' in Canada on Monday.

Read more
4 Mar 2021 12:46

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

Read more
4 Feb 2021 14:18

Amryt signs multi-regional distribution deals with Medison

(Sharecast News) - Commercial-stage biopharmaceuticals company Amryt Pharma announced the signing of multi-regional distribution agreements with Medison Pharma on Thursday.

Read more
4 Feb 2021 12:14

Amryt Pharma Signs Drug Distribution Agreements With Medison Pharma

Amryt Pharma Signs Drug Distribution Agreements With Medison Pharma

Read more
20 Jan 2021 21:32

IN BRIEF: Amryt Receives Reimbursement Approval For Myalepta

IN BRIEF: Amryt Receives Reimbursement Approval For Myalepta

Read more
23 Dec 2020 19:50

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

Read more
17 Dec 2020 13:38

Amryt gets reimbursement approval for 'Lojuxta' in Saudi Arabia

(Sharecast News) - Biopharmaceutical company Amryt announced on Thursday that Ministry of Health reimbursement approval has been granted for 'Lojuxta', or lomitapide, in Saudi Arabia.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.